Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
opioid |
| gptkbp:CASNumber |
gptkb:2094146-57-0
|
| gptkbp:controlledSubstanceSchedule |
gptkb:United_States
|
| gptkbp:effect |
analgesic
respiratory depression euphoria |
| gptkbp:hasMolecularFormula |
gptkb:C23H28N2O
|
| https://www.w3.org/2000/01/rdf-schema#label |
MPO-12
|
| gptkbp:isAnalogOf |
gptkb:U-47700
|
| gptkbp:IUPACName |
gptkb:N-(2-methoxyphenyl)-N-[(1R,2R)-2-(pyrrolidin-1-yl)cyclohexyl]propanamide
|
| gptkbp:legalStatus |
gptkb:Schedule_I_(US)
|
| gptkbp:PubChem_CID |
137332322
|
| gptkbp:relatedTo |
recreational drug
|
| gptkbp:routeOfAdministration |
oral
intravenous intranasal |
| gptkbp:sells |
research chemical
|
| gptkbp:subjectOf |
forensic toxicology studies
|
| gptkbp:wasFirstIdentified |
2019
|
| gptkbp:bfsParent |
gptkb:400GBASE-DR4
|
| gptkbp:bfsLayer |
7
|